Leaflet PROPECIA 1mg film-coated tablets

Indicated for: benign prostatic hyperplasia; androgenetic alopecia

Route of administration: oral

Substance: finasteride (enzyme inhibitor)

ATC: D11AX10 (Dermatologicals | Other dermatological preparations | Other dermatologicals)

Precautions:
Contraindicated during pregnancy
Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Teratogenic / fetal risk
Teratogenic / fetal risk

This medicine may affect fetal development.

Finasteride is a medication used to treat benign prostatic hyperplasia (BPH) and androgenetic alopecia (male pattern hair loss). It belongs to the class of 5-alpha-reductase inhibitors and works by blocking the conversion of testosterone into dihydrotestosterone (DHT), a hormone involved in prostate enlargement and hair loss.

- In benign prostatic hyperplasia, finasteride helps reduce the size of the prostate, improving urinary symptoms such as difficulty urinating or frequent urination, and may lower the risk of acute urinary retention or the need for surgery.
- In androgenetic alopecia, finasteride slows hair loss and may promote hair regrowth, particularly in the crown area of the scalp.

The medication is taken orally, usually once daily, and effects may become noticeable after several months of treatment.

Side effects may include decreased libido, erectile dysfunction, reduced ejaculate volume, and, rarely, allergic reactions or depression. It is important to use finasteride as prescribed by a healthcare provider, and pregnant women or those who may become pregnant should avoid handling crushed or broken tablets, as the medication can affect fetal development.

General data about PROPECIA 1mg

  • Substance: finasteride
  • Date of latest medicines list: 01-06-2026
  • Product code: W51272001
  • Concentration: 1mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 28
  • Product type: Original
  • Price: 184.18 RON
  • Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

  • Manufacturer: MERCK SHARP & DOHME B.V. - OLANDA
  • Holder: MERCK SHARP & DOHME ROMANIA S.R.L. - ROMANIA
  • Number: 9711/2017/01
  • Shelf life: 3 years

Pharmaceutical forms available for finasteride

Concentrations available for finasteride

  • 1mg
  • 2.275mg/ml
  • 5mg

Combinations with other substances